Cargando…

Bone-targeted therapy in prostate cancer

Detalles Bibliográficos
Autor principal:	Saad, Fred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041557/ https://www.ncbi.nlm.nih.gov/pubmed/26217136 http://dx.doi.org/10.1016/j.ejcsup.2013.07.038

Ejemplares similares

Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate
por: Saad, Fred
Publicado: (2022)

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
por: Dorff, Tanya B, et al.
Publicado: (2018)

Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer
por: Saylor, Philip J
Publicado: (2014)

Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer
por: Saad, Fred, et al.
Publicado: (2021)

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
por: El-Amm, Joelle, et al.
Publicado: (2013)

Editorial for the Special Edition of Advanced Prostate Cancer: From Bench to Bedside
por: Saad, Fred
Publicado: (2023)

KLK-targeted Therapies for Prostate Cancer
por: Hannu, Koistinen, et al.
Publicado: (2014)

In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
por: Chen, Lingxiao, et al.
Publicado: (2018)

From Therapy Resistance to Targeted Therapies in Prostate Cancer
por: Moreira-Silva, Filipa, et al.
Publicado: (2022)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease
por: Straign, Desiree M., et al.
Publicado: (2021)

Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
por: Devlies, Wout, et al.
Publicado: (2021)

Bone Targeted Therapies for Bone Metastasis in Breast Cancer
por: Razaq, Wajeeha
Publicado: (2013)

Targeted nonviral gene therapy in prostate cancer
por: Altwaijry, Najla, et al.
Publicado: (2018)

ADRB2-Targeting Therapies for Prostate Cancer
por: Kulik, George
Publicado: (2019)

Advances in targeted alpha therapy for prostate cancer
por: De Vincentis, G, et al.
Publicado: (2019)

Targeting aldehyde dehydrogenase for prostate cancer therapies
por: Ma, Miao, et al.
Publicado: (2022)

PSMA-targeted therapy for non-prostate cancers
por: Wang, Jarey H., et al.
Publicado: (2023)

Targeting Bone Remodeling by Isoflavone and 3,3′-Diindolylmethane in the Context of Prostate Cancer Bone Metastasis
por: Li, Yiwei, et al.
Publicado: (2012)

Bone-targeted nanoplatform enables efficient modulation of bone tumor microenvironment for prostate cancer bone metastasis treatment
por: Zhang, Xiangyu, et al.
Publicado: (2022)

Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
por: Rogowski, Paul, et al.
Publicado: (2021)

Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey
por: Hutton, Brian, et al.
Publicado: (2013)

High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality
por: Dariane, Charles, et al.
Publicado: (2022)

Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter–Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth
por: Sung, Shian-Ying, et al.
Publicado: (2016)

New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
por: Godbole, Abhijit M., et al.
Publicado: (2011)

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
por: Bonfil, R.D., et al.
Publicado: (2008)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021)

Targeting IKKε in Androgen-Independent Prostate Cancer Causes Phenotypic Senescence and Genomic Instability
por: Gilbert, Sophie, et al.
Publicado: (2022)

From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis
por: Thobe, Megan N., et al.
Publicado: (2011)

Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
por: Aapro, Matti, et al.
Publicado: (2010)

Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer
por: Rosenfeld, Lior, et al.
Publicado: (2020)

Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
por: Todenhöfer, Tilman, et al.
Publicado: (2015)

Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
por: Gdowski, Andrew S, et al.
Publicado: (2017)

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
por: Heidenreich, Axel, et al.
Publicado: (2019)

Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer
por: Gogola, Samantha, et al.
Publicado: (2023)

Emerging Targeted Therapies for Castration-Resistant Prostate Cancer
por: Adamo, Vincenzo, et al.
Publicado: (2012)

Castration-resistant prostate cancer: potential targets and therapies
por: Parray, Aijaz, et al.
Publicado: (2012)

The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor
por: Aragon-Ching, Jeanny B.
Publicado: (2014)

Changing the History of Prostate Cancer with New Targeted Therapies
por: Hernando Polo, Susana, et al.
Publicado: (2021)

Can bone scans guide therapy with radium-223 dichloride for prostate cancer bone metastases?
por: Gayed, Isis, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lul90vlup02bt63q6nnppjn6c2